Genetic and environmental contributions to platelet aggregation: the Framingham heart study.
about
Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart StudyVAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNAPlatelet function and ageingRelationship of arachidonic acid concentration to cyclooxygenase-dependent human platelet aggregationCyclooxygenase-1 haplotype modulates platelet response to aspirinCommon variations in platelet glycoproteins: pharmacogenomic implicationsPrimary prevention of coronary heart disease with aspirinSex difference in the antiplatelet effect of aspirin in patients with strokeClinical implications of aspirin resistanceDiscovery of novel GPVI receptor antagonists by structure-based repurposingPlatelet microRNA-mRNA coexpression profiles correlate with platelet reactivity.Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376cPlatelet adhesion onto immobilized fibrinogen under arterial and venous in-vitro flow conditions does not significantly differ between men and women.Inherited dysfunctional nitric oxide signaling and the pathobiology of atherothrombotic disease.Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group.Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development.Implementing genotype-guided antithrombotic therapy.Relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham heart studyThe genetics of normal platelet reactivity.Transcription profiling in human platelets reveals LRRFIP1 as a novel protein regulating platelet function.Genetic determinants of on-aspirin platelet reactivity: focus on the influence of PEAR1.Genetics of the Framingham Heart Study populationCellular phenotypes and the genetics of hypertension.Prakriti (Ayurvedic concept of constitution) and variations in platelet aggregation.Association of single nucleotide polymorphisms on chromosome 9p21.3 with platelet reactivity: a potential mechanism for increased vascular disease.The complex transcriptional landscape of the anucleate human platelet.Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by raceGenome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists.Aspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistance.Single nucleotide polymorphism network: a combinatorial paradigm for risk prediction.Antithrombotic therapy in patients with acute coronary syndrome in the intermountain heart collaborative studyAging of the nitric oxide system: are we as old as our NO?Clinicians' guide to statistics for medical practice and research: part I.The genetics of common variation affecting platelet development, function and pharmaceutical targeting.Novel family-based approaches to genetic risk in thrombosis.Nitric oxide and its relationship to thrombotic disorders.Polymorphism in the protease-activated receptor-4 gene region associates with platelet activation and perioperative myocardial injury.Identification of a specific intronic PEAR1 gene variant associated with greater platelet aggregability and protein expression.Phenotyping patient-derived cells for translational studies in cardiovascular disease.Genetic association analysis highlights new loci that modulate hematological trait variation in Caucasians and African Americans.
P2860
Q21261432-0695F17E-9A8F-414D-8470-111BF9A93D34Q24609475-8D8FD1E6-F07F-4C4B-81CD-AB933FE3CB62Q26749231-CA8B396D-76BC-4C0D-A722-EBE85519FA67Q28165301-F19134EF-73ED-4EDB-9B63-AB17C48C0BDEQ28191434-09BAD2DB-83D7-4A17-BE8E-2FF0C1E39338Q28191774-02C35C1E-86E4-4B84-B4A8-A1642F1F602FQ28192984-E5CF92FA-84D2-46F4-9FEF-A76F58DD1A90Q28196479-677B4669-8A80-45C8-A84E-29B4EE6B1E3AQ28221576-D5622757-9FA3-42E2-8EEA-5F07CBF0C184Q28540147-08DEB467-F8E1-4FE3-866A-AFA0E8A143F1Q30500885-910FE015-FA5B-4307-8235-9C2F1254926CQ30558959-EF55A7A6-9EE8-46D6-B8B0-3A32865D8E79Q33282914-837EA2F7-EF92-4BF4-A2B5-EF3F9479347DQ33642069-4F8E653B-8AE9-4C0F-AAEC-837CE9E431F7Q33863833-7C463113-E38D-4481-A37A-E8303A80F074Q33988457-DA811D71-E6E5-4E08-BF50-A34190287825Q33990428-CBEA4533-283E-4C18-842D-F3EEC73A25B5Q34023032-9BEE9B41-56DD-4221-B2B5-B19BF07BC566Q34282183-05810939-344E-443F-961D-46F669DE12F2Q34374101-FC50E490-FBAA-401D-8572-6DA879E6F0C0Q34435298-24703A86-1F75-4969-90AE-1DB6C2111BBDQ34458072-1027BCE8-EF82-4FE5-822B-BE0A2ED0532DQ34492797-22A638EF-E6F9-4746-AB65-21AFE5218710Q34507730-771FBC2F-F2B9-4564-AFD1-F6E2C7ED9FF8Q34543464-E8F859F2-10E0-47BD-ABB1-389984F3E5CCQ34549628-2ECCC4F0-DF2F-4A61-9013-7CEDAAA96146Q34580117-89AB4CA1-9B38-41DA-8B1E-125FEFB394CBQ34674600-5EFDE1F5-9348-4D4A-A7A5-85242D0E4131Q34771381-6DA207BE-7EA6-44A7-849C-2F00BE073363Q34989717-3A322AD2-2504-4497-9FFD-9670469CCA7BQ34997324-9490F606-BFE9-4CB1-8343-206C6E637262Q35026305-92C3D352-C7B9-4D51-A874-DA972F703BA1Q35063619-D76E8813-93B8-4603-88F7-E25D52D7395FQ35149898-AB26C9FC-7E98-4A3B-88E4-DF094683BDF7Q35181584-EEB1A5B4-DAE7-4E6F-ABD7-298CFBBECB15Q35181680-12725166-AC65-4D23-9B93-0816CA4A570BQ35212303-B965CC32-6C12-4470-9478-C23BCD7412A6Q35230231-4B253793-761D-4DC5-AE89-8B83067F7D9EQ35686793-28BF5A06-F2C3-43FD-9D82-7D9391BD0DB1Q36234313-8C8CEFE9-2CB7-4BD8-B5B6-B1037580531A
P2860
Genetic and environmental contributions to platelet aggregation: the Framingham heart study.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Genetic and environmental cont ...... n: the Framingham heart study.
@en
type
label
Genetic and environmental cont ...... n: the Framingham heart study.
@en
prefLabel
Genetic and environmental cont ...... n: the Framingham heart study.
@en
P2093
P1433
P1476
Genetic and environmental cont ...... on: the Framingham heart study
@en
P2093
C J O'Donnell
Framingham Heart Study
G H Tofler
K Lindpaintner
P A Sutherland
R A D'Agostino
P304
P356
10.1161/01.CIR.103.25.3051
P407
P577
2001-06-01T00:00:00Z